Asthma is an enormous public health problem that continues to grow larger, in part because scientists don’t fully understand how it is caused. Existing therapies don’t cure the disease and often don’t ...

Asthma is an enormous public health problem that continues to grow larger, in part because scientists don't fully understand how it is caused. Existing therapies don't cure the disease and often don't ...

PHILADELPHIA -- Asthma is an enormous public health problem that continues to grow larger, in part because scientists don't fully understand how it is caused. Existing therapies don't cure the disease ...

In a significant stride toward combating asthma, researchers have discovered a promising new pathway for treatment, which offers hope for millions worldwide grappling with the chronic, ...

Toll-like receptors (TLRs) are pattern-recognition receptors (PRRs) that play an essential role in activation of the innate immune system, which in turn activates adaptive immunity (Medzhitov 2001; ...

Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...

Researchers have identified a molecular pathway that helps explain how an enzyme elevated in asthma patients can lead to increased mucus production and inflammation that is characteristic of the lung ...

Asthma is an enormous public health problem that continues to grow larger, in part because scientists don't fully understand how it is caused. Existing therapies don't cure the disease and often don't ...

The appraisal committee considered evidence submitted by AstraZeneca, a review of this submission by the evidence assessment group (EAG), and responses from stakeholders. See the committee papers for ...

One in ten school-aged children in Australia have a current diagnosis of asthma. Every year, there are around 40,000 asthma hospitalizations and over 40 per cent of these are in children aged younger ...